• Tue, April 5, 2016
  • Wed, April 6, 2016
  • Mon, April 4, 2016

Keay Nakae Initiated (ALNY) at Strong Buy and Held Target at $93 on, Apr 4th, 2016

Keay Nakae of Chardan Capital, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $93 on, Apr 4th, 2016.

Keay has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 0 agree with Keay's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Keay


  • Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $81 on, Friday, March 11th, 2016
  • Paul Matteis of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 16th, 2016
  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $154 on, Wednesday, January 20th, 2016

Like: 👍